According to Weili Medical's announcement, on December 18, 2025, it received a letter from the controlling shareholder Gaobo Investment Co., Ltd., that it pledged 16 million shares on December 17. The pledge holder was Macau International Bank Co., Ltd., accounting for 17.39% of its shares and 5.48% of the company's total share capital. The capital was used for production and operation. As of December 18, Gaobo Investment held 92.92 million shares of the company, accounting for 31.53% of the total share capital, and pledged 46 million shares, accounting for 49.99% of its shares and 15.76% of the company's total share capital. This pledge will not lead to a change in actual control, and there is currently no risk of closing the position.

According to Weili Medical's announcement, on December 18, 2025, it received a letter from the controlling shareholder Gaobo Investment Co., Ltd., that it pledged 16 million shares on December 17. The pledge holder was Macau International Bank Co., Ltd., accounting for 17.39% of its shares and 5.48% of the company's total share capital. The capital was used for production and operation. As of December 18, Gaobo Investment held 92.92 million shares of the company, accounting for 31.53% of the total share capital, and pledged 46 million shares, accounting for 49.99% of its shares and 15.76% of the company's total share capital. This pledge will not lead to a change in actual control, and there is currently no risk of closing the position.